You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

~ Buy the AEMCOLO (rifamycin sodium) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR AEMCOLO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for AEMCOLO

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04082780 ↗	Rifamycin in Minimal Hepatic Encephalopathy	Recruiting	Hunter Holmes Mcguire Veteran Affairs Medical Center	Phase 2	2019-09-01	This is a randomized double-blind placebo-controlled trial of MHE in patients with cirrhosis using rifamycin SV-MMX 600mg BID vs placebo for 30 days with PK, safety, microbiota, brain function and brain MRI endpoints.
NCT04501380 ↗	Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)	Recruiting	Bradley A. Connor, M.D.	Phase 2	2020-06-30	Open label interventional randomized pilot study utilizing two dosing regimens of AEMCOLO. The goal of this study is to evaluate effectiveness of a novel antibiotic, AEMCOLO (Rifamycin SV MMX) in the treatment of Small intestinal bacterial overgrowth (SIBO).
NCT04501380 ↗	Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)	Recruiting	Bradley Connor	Phase 2	2020-06-30	Open label interventional randomized pilot study utilizing two dosing regimens of AEMCOLO. The goal of this study is to evaluate effectiveness of a novel antibiotic, AEMCOLO (Rifamycin SV MMX) in the treatment of Small intestinal bacterial overgrowth (SIBO).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for AEMCOLO

Condition Name

Chart
Table

Condition Name for AEMCOLO
Intervention	Trials
Cirrhosis, Liver	1
Gastrointestinal Disease	1
Gastrointestinal Infection	1
Hepatic Encephalopathy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for AEMCOLO
Intervention	Trials
Gastrointestinal Diseases	1
Digestive System Diseases	1
Liver Cirrhosis	1
Hepatic Encephalopathy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for AEMCOLO

Trials by Country

Map
Table

Trials by Country for AEMCOLO
Location	Trials
United States	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for AEMCOLO
Location	Trials
New York	1
Virginia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for AEMCOLO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for AEMCOLO
Clinical Trial Phase	Trials
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for AEMCOLO
Clinical Trial Phase	Trials
Recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for AEMCOLO

Sponsor Name

Chart
Table

Sponsor Name for AEMCOLO
Sponsor	Trials
Bradley A. Connor, M.D.	1
Bradley Connor	1
Hunter Holmes Mcguire Veteran Affairs Medical Center	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for AEMCOLO
Sponsor	Trials
Other	2
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.